Diagnosis, diagnostics, Immunodiagnosis & Immunodiagnostics:  

9087.  del Rio M, Bansal I, Maeda K, Skarf B, Brar I. Progressive vision loss in a man from Cameroon. Clin Infect Dis. 2003 Nov 1;37(9):1199-200, 1255-6.

9088.  Kolekar S, Sundaram P, Joshi JM. Unusual diagnostic aid for a common tropical disease.Indian J Chest Dis Allied Sci. 2003 Oct-Dec;45(4):257-9.

9089.  Patil JA, Patil AD, Ramani SK. Filarial "dance" in breast mass. AJR Am J Roentgenol. 2003 Oct;181(4):1157-8.

9090.  Rahmah N, Shenoy RK, Nutman TB, Weiss N, Gilmour K, Maizels RM, Yazdanbakhsh M, Sartono E. Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis.Trop Med Int Health. 2003 Oct;8(10):895-900.

Pathogenesis:

9091.  Boatin BA. The current state of the Onchocerciasis Control Programme in West Africa. Trop Doct. 2003 Oct;33(4):209-14.

9092.  Foster A. Vision 2020--the Right to Sight. Trop Doct. 2003 Oct;33(4):193-4.

9093.  Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis. 2003 Nov 1;188(9):1371-81. Epub 2003 Oct 31.

9094.  Timmann C, Abraha RS, Hamelmann C, Buttner DW, Lepping B, Marfo Y, Brattig N, Horstmann RD. Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus. Br J Dermatol. 2003 Oct;149(4):782-7.

Vaccines:

9095.  Hoerauf A. Control of filarial infections: not the beginning of the end, but more research is needed. Curr Opin Infect Dis. 2003 Oct;16(5):403-10. Review.

Therapy:

9096.  Foster A. Vision 2020--the Right to Sight. Trop Doct. 2003 Oct;33(4):193-4. Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis. 2003 Nov 1;188(9):1371-81. Epub 2003 Oct 31.

9097.  Ndyomugyenyi R, Kabatereine N. Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages. Trop Med Int Health. 2003 Nov;8(11):997-1004.

9098.  Sama MT, Homeida M, Ngang P, Liese BH, Amazigo U, Seketeli A. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda. Trop Doct. 2003 Oct;33(4):237-41.